Radiation energy deposition

Radiation energy deposition refers to the physical phenomenon where ionizing radiation transfers energy to atoms and molecules within biological tissues. This process is the fundamental mechanism behind radiotherapy, where the goal is to deposit sufficient energy to cause lethal DNA damage—either directly through bond breakage or indirectly through the radiolysis of water and subsequent generation of reactive oxygen species (ROS). While not a biological molecule like a receptor or enzyme, radiation energy deposition is the primary 'trigger' for a cascade of biological responses, including DNA repair pathways, cell cycle checkpoints, and programmed cell death. In a clinical context, this process is modulated by various pharmacological agents. Radiosensitizers, such as platinum-based compounds or antimetabolites, are used to increase the susceptibility of tumor cells to the damage caused by energy deposition. Conversely, radioprotectors like amifostine are employed to shield healthy tissues from the deleterious effects of the radiation. Because it is a physical process rather than a discrete protein target, it lacks a canonical molecular structure and is instead characterized by parameters such as absorbed dose (measured in Grays) and linear energy transfer (LET).

Other names

Ionizing radiation exposureAbsorbed doseLinear energy transferRadiotherapy effectEnergy transfer process

Not applicable as a molecular target; drugs act as radiosensitizers to enhance energy-induced damage or radioprotectors to scavenge free radicals generated by the process.